Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Next Previous
Trial Profile

Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

Status: Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 26 Sep 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Antithymocyte globulin (Primary) ; Bortezomib (Primary) ; Busulfan (Primary) ; Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Fludarabine (Primary) ; Mycophenolate mofetil (Primary) ; Rituximab (Primary) ; Tacrolimus (Primary)
  • Indications Graft-versus-host disease; Haematological disorders
  • Focus Therapeutic Use

Most Recent Events

  • 18 Sep 2023 Planned End Date changed from 30 Aug 2025 to 18 Sep 2023.
  • 18 Sep 2023 Planned primary completion date changed from 30 Aug 2025 to 18 Sep 2023.
  • 18 Sep 2023 Planned initiation date changed from 30 Sep 2022 to 2 Mar 2022.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top